Saudi Hospital Joins International Dementia Registry to Advance Research
KFSH becomes the first Middle Eastern healthcare institution to join the International…
M42’s IROS Launches UAE’s First Genomics-Driven Clinical Trial to Prevent Alzheimer’s Disease
M42's IROS has launched the UAE's first genomics-driven clinical trial to prevent…
Sysmex Launches an Assay Kit for Identifying p-Tau217 in the Blood, a Biomarker Related to Alzheimer’s Disease
Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui) announced that it has…
New US$ 1 Million Prize Competition Aims to Revolutionize Alzheimer’s Research by Leveraging Agentic AI Systems
The Alzheimer’s Disease Data Initiative (AD Data Initiative) today announced the Alzheimer’s Insights AI Prize…
